Author | Year of publication | Sample size | Patient mean age | Sex (M/F) | BMI | Steroid/control group | Drain/blocks/anesthesia | Cocktail | Steroid Used | Administration Method | Type of Knee arthroplasty | Other intervention protocol |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kwon | 2014 | 76 | 69.3 | 0/76 | 25.9 | 76/76 | ?/none/SA | 10 mg morphine, 300 mg ropivacaine,30 mg ketorolac, 300 μg of 1:1000 epinephrine | 40 mg Triamcinolone | SLIA IAPC | Cemented TKA | Preoperative celecoxib, ultracet,pregabalin |
 |  |  |  |  |  |  |  |  |  |  | Unresurfaced patella | Postoperative PCA |
Yue | 2013 | 72 | 69.75 | 8/64 | 25.685 | 36/36 | All drains/none/GA | 0.75Â % ropivacaine 30Â ml, 1:1000 adrenaline 0.5Â ml | 7Â mg Betamethasone | SLIA IAPC | TKA(unclassified) | Â |
 |  |  |  |  |  |  |  |  |  |  |  | Postoperative PCA, celecoxib |
Ikeuchi | 2014 | 40 | 76.5 | 6/34 | ? | 20/20 | All drains/none/GA | 20Â ml of 0.75Â % ropivacaine, 400Â mg of isepamicin | 6.6Â mg Dexamethasone | Peri-articular tissues | Cemented TKA | Â |
 |  |  |  |  |  |  |  |  |  |  | Unresurfaced patella | Postoperative PCA, loxoprofen |
Chia | 2013 | 127 | 66.93 | ? | 31.15 | 84/43 | None/none/SA | 0.2Â % ropivacaine and 100Â ml 1:1000 adrenaline | Triamcinolone | SLIA IAPC | Cemented TKA, | Â |
 |  |  |  |  |  |  |  |  | 40 mg in subgroup1, 80 mg in subgroup2 |  | Resurfaced patella | Postoperative celecoxib |
Seah | 2011 | 100 | 66.65 | ? | 27 | 50/50 | ?/none/SA or GA | 0.5Â ml/kg of 1:200,000 epinephrine and 0.5Â % bupivacaine | 40Â mg of Triamcinolone | SLIA IAPC | Cemented TKA, | Â |
 |  |  |  |  |  |  |  |  |  |  |  | Postoperative PCA |
Christensen | 2009 | 76 | 65.508 | 23/53 | 33.9 | 39/37 | ?/FNB/GA | 80Â mg of bupivacaine, 4Â mg morphine, 300Â mg epinephrine, 100Â mg clonidine, 750Â mg cefuroxime | 40Â mg Methylprednisolone | SLIA IAPC | TKA(unclassified) | Preoperative elecoxib, oxycodone or acetaminophen |